Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,958 public trials 634 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer

NCT00392821

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Cancer, +9 more
Locations
  • Florida Hospital Cancer Institute Orlando, Florida, United States
  • Northeast Georgia Medical Center Gainesville, Georgia, United States
  • Wellstar Cancer Research Marietta, Georgia, United States
  • Baptist Hospital East Louisville, Kentucky, United States
View Trial Details
Completed

BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)

NCT01354431

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations
  • UCSD Moores Cancer Center La Jolla, California, United States
  • Ucla Los Angeles, California, United States
  • Samuel Oschin Comprehensive Cancer Inst. Los Angeles, California, United States
  • Stanford Cancer Center Stanford, California, United States
View all 41 locations
View Trial Details
Completed

A Retrospective Medical Record Review of First-Line Sunitinib Administration Schedules and Outcomes Among Patients With mRCC in Latin America (LA)

NCT04115189

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Instituto Médico Especializado Alexander Fleming Buenos Aires, Argentina
  • Sanatorio del Salvador - Cordoba Córdoba, Argentina
  • Centro Oncológico de Integración Regional in Mendoza Mendoza, Argentina
  • Escola Paulista de Medicina - UNIFESP São Paulo, Brazil
View Trial Details
Completed

Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer

NCT00920816

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +8 more
Locations
  • Advanced Medical Specialties Miami, Florida, United States
  • Advanced Medical Specialties Miami, Florida, United States
  • Illinois Cancer Specialists Arlington Heights, Illinois, United States
  • Illinois Cancer Specialists Niles, Illinois, United States
View all 125 locations
View Trial Details
Completed

CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer

NCT03628716

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • H. Lee Moffitt Cancer Center & Research Institute, Inc. Tampa, Florida, United States
  • Norton Cancer Institute, Norton Healthcare Pavilion Louisville, Kentucky, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute (DFCI) Boston, Massachusetts, United States
View Trial Details
Completed

Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566

NCT02315066

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +60 more
Locations
  • The Angeles Clinic And Research Institute, A Cedars-Sinai Affiliate Los Angeles, California, United States
  • Keck Hospital of USC Los Angeles, California, United States
  • LAC+USC Medical Center Los Angeles, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 30 locations
View Trial Details

Related conditions